GLP-1 receptor agonists after ACS in diabetes: credible plaque signals, but comparators, confounding, and access will decide impact

Acta Diabetologica 2026

View at publisher

Authors: Mulavagili Vijayasimha

DOI: 10.1007/s00592-026-02649-w

Cited by: 0

References: 5

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Cardiovascular Risks and Lipoproteins Antiplatelet Therapy and Cardiovascular Diseases

References 5